Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies

This is a live story built from multiple sources. It may evolve quickly.

Coverage meter • 1 min window

Back to home Open top source

T theguardian.com

What’s included

Top recent items from this story.

1 items • 1 unique links

The Guardian - US 4 days ago • theguardian.com

Trades of Eli Lilly shares were made on Trump’s behalf as drugmaker benefitted from his policies

Filings reveal $220m to $750m in trades on US president’s behalf in first quarter of 2026, including securities linked to largest US companiesHundreds of thousands of dollars was invested in Eli Lilly on Donald Trump’s b…

Open